Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7389 p224
25 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Infection a risk with preservative-free drops

Cordelia Molloy/Science Photo Library

Traditional glass dropper bottles

Traditional glass dropper bottles are at risk of microbial contamination

Some patients using preservative-free eye drops in multiple-use containers could be at risk of serious eye infection due to microbial contamination of the product, according to the authors of a new study (British Journal of Ophthalmology 2006;90:139). They found the overall incidence of contamination in used preservative-free bottles to be 8.4 per cent (95 per cent confidence interval 3.71–15.9).

Preservative-free eye drops can be ordered from specials manufacturers and come in traditional glass containers for use over a number of days. The authors explain that these specials are given arbitrary expiry dates based on practical considerations and that the generally accepted timeframe for use is three days in an inpatient setting and up to seven days in an outpatient setting.

The investigators collected 95 used eye drop bottles at day three (inpatients) and day seven (outpatients), and the drops were cultured for microbial growth. Four per cent of bottles collected from inpatients were contaminated compared with 25 per cent of outpatient bottles — a statistically significant difference (P<0.01). Of the 53 eye drop bottles containing antibiotics, none showed any microbial contamination. Contaminated bottles contained acetylcysteine, prednisolone or hypromellose as active ingredients.

Several of the contaminated bottles grew more than one type of organism. The most commonly isolated organism was Staphylococcus aureus, with an occurrence of 4.5 per cent.

The authors state the design of multiple-dose eye drop containers, spillage of contents and poor patient administration technique as possible causes of contamination. Many patients experience allergy or irritation from preservatives in eye drops, but are unable to use single-dose-unit eye drops because they are either unavailable or prohibitively expensive. Furthermore, patients with compromised ocular surface defences may be at risk of serious eye infections, say the authors.

The authors suggest that doctors exercise caution when prescribing multiple-use eye drops without preservative in patients at high risk of infection.

Back to Top


©The Pharmaceutical Journal